Digital Pharmacovigilance and Disease Surveillance: Combining Traditional and Big-Data Systems for Better Public Health
Open Access
- 14 November 2016
- journal article
- review article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 214 (suppl 4), S399-S403
- https://doi.org/10.1093/infdis/jiw281
Abstract
The digital revolution has contributed to very large data sets (ie, big data) relevant for public health. The two major data sources are electronic health records from traditional health systems and patient-generated data. As the two data sources have complementary strengths-high veracity in the data from traditional sources and high velocity and variety in patient-generated data-they can be combined to build more-robust public health systems. However, they also have unique challenges. Patient-generated data in particular are often completely unstructured and highly context dependent, posing essentially a machine-learning challenge. Some recent examples from infectious disease surveillance and adverse drug event monitoring demonstrate that the technical challenges can be solved. Despite these advances, the problem of verification remains, and unless traditional and digital epidemiologic approaches are combined, these data sources will be constrained by their intrinsic limits.Keywords
This publication has 28 references indexed in Scilit:
- Reassessing Google Flu Trends Data for Detection of Seasonal and Pandemic Influenza: A Comparative Epidemiological Study at Three Geographic ScalesPLoS Computational Biology, 2013
- Realities of data sharing using the genome wars as case study - an historical perspective and commentaryEPJ Data Science, 2013
- Digital EpidemiologyPLoS Computational Biology, 2012
- Physicians should be paid to report adverse drug reactions, experts sayCMAJ : Canadian Medical Association Journal, 2012
- Assessing Vaccination Sentiments with Online Social Media: Implications for Infectious Disease Dynamics and ControlPLoS Computational Biology, 2011
- Assessing Google Flu Trends Performance in the United States during the 2009 Influenza Virus A (H1N1) PandemicPLOS ONE, 2011
- Survey to assess public awareness of patient reporting of adverse drug reactions in Great BritainJournal of Clinical Pharmacy & Therapeutics, 2011
- The Use of Twitter to Track Levels of Disease Activity and Public Concern in the U.S. during the Influenza A H1N1 PandemicPLOS ONE, 2011
- Detecting influenza epidemics using search engine query dataNature, 2009
- Determinants of Under-Reporting of Adverse Drug ReactionsDrug Safety, 2009